Ingevity Corporation NGVT
73.00
1.21
1.69%
as of 25 Sep
- Market cap
- $2.5B
- P/E
- 47.4×
Follow NGVT
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(37.38%) | (148.60%) | (93.46%) | 64.44% | |
| (3.26%) | (9.10%) | (6.90%) | 3.16% | ||
ROIC |
10.67% | (2.47%) | (2.43%) | 9.33% | |
Return on Tangible Assets |
(8.90%) | (23.18%) | (16.55%) | 6.91% | |
Average Days of Receivables |
58.54 | 39.76 | 46.86 | 49.01 | |
Free Cash Flow per Share |
6.60 | 7.65 | 6.97 | 4.47 | |
Free Cash Flow |
239.60 | 277.10 | 245.80 | 154.90 | |
Capital Expenditures |
(59.00) | (54.10) | (58.00) | (56.10) | |
Piotroski F-Score |
6.00 | 5.00 | 4.00 | 6.00 | |
| Other line items | |||||
Cash ROIC |
21.64% | 26.10% | 23.34% | 16.40% | |
Accounts Receivable Turnover |
5.86 | 9.02 | 7.48 | 6.65 | |
Accounts Payable Turnover |
5.72 | 7.57 | 7.36 | 7.21 | |
Inventory Turnover |
2.48 | 3.70 | 3.17 | 3.65 | |
Average Days of Payables |
65.28 | 47.56 | 43.59 | 47.02 | |
Days of Inventory on Hand |
125.31 | 96.15 | 104.42 | 82.29 | |
Tax Rate |
(0.43) | 0.06 | 0.04 | (0.33) | |
Research and Development Expense of Revenue |
2.40% | 2.43% | 2.39% | 2.34% | |
Selling, General and Administrative Expense of Revenue |
15.35% | 14.66% | 14.43% | 14.25% | |
Share Based Compensation of Revenue |
1.52% | 1.57% | 1.61% | 1.62% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
(4.53) | (1.98) | (2.38) | 3.91 | |
Depreciation/Fixed assets |
0.46 | 0.48 | 0.48 | 0.18 | |
Capex/Depreciation |
(0.21) | (0.19) | (0.20) | (0.56) | |
Revenue per Share |
28.87 | 32.23 | 33.40 | 33.45 | |
Operating CF per Share |
8.22 | 9.14 | 8.62 | 6.08 | |
Capex per Share |
(1.62) | (1.49) | (1.65) | (1.62) | |
Capex to Sales |
0.06 | 0.05 | 0.05 | 0.05 | |
Net Profit Margin |
(6.29%) | (14.31%) | (10.85%) | 4.65% |
Columns are period end dates